Funded Tech Companies
Cybrexa Therapeutics
Researching who invested in Cybrexa Therapeutics? Elm Street Ventures, HighCape Partners and Cycle Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Cybrexa Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
395 Winchester Ave. 5 Science Park
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Cybrexa is a privately funded biotechnology company dedicated to developing an entirely new class of small molecule DNA repair inhibitors (TSDs) that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/11/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Kevin Didden
Chief Executive Officer
Per Hellsund
Chief Medical Officer
Arthur DeCillis
Chief Medical Officer
Peter Glazer
Chief Scientific Officer
Vishwas Paralkar
Co-Founder
Ranjit Bindra
Company Investors
- Elm Street Ventures
- HighCape Partners
- Cycle Capital
- Connecticut Innovations
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs